HCA Healthcare Inc. ($HCA) Stock Forecast: Down 5.3% Today

What is HCA Healthcare Inc.?

HCA Healthcare (NYSE: HCA) is a leading healthcare services provider in the United States, offering a wide range of medical services to patients across its network of hospitals and outpatient facilities. The company has recently reported mixed Q4 earnings but issued a cautious revenue outlook for 2026.

Why is HCA Healthcare Inc. going down?

HCA stock is down 5.3% on Jan 28, 2026 14:45

• Despite reporting strong Q4 earnings, HCA Healthcare's stock experienced a bearish movement as the cautious revenue guidance for 2026 fell below analyst expectations.
• The announcement of a new $10 billion share repurchase program and an increased quarterly dividend were not enough to offset concerns about the company's future revenue growth.
• The market may be reacting negatively to economic headwinds, which could impact HCA's revenue projections for the upcoming year.
• The bullish sentiment on outpatient expansion might not have been sufficient to reassure investors about the company's overall growth prospects, leading to the bearish movement in the stock price.

HCA Price Chart

HCA Technical Analysis

HCA News

CH Robinson Worldwide Inc stock hits all-time high at 180.38 USD

CH Robinson Worldwide Inc (CHRW) stock has reached an all-time high of $180.38, surpassing its previous 52-week high. The logistics company has a market capitalization of $21.15 billion, with its stock up 66.91% over the past year. While the stock's RSI suggests it's in overbought territory and its P/E ratio of 35.85 indicates it's overvalued compared to its InvestingPro Fair Value, analysts have a positive outlook, citing productivity gains from AI implementations and an improved market position.

https://www.investing.com/news/company-news/ch-robinson-worldwide-inc-stock-hits-alltime-high-at-18038-usd-93CH-4467843

HCA Healthcare (NYSE:HCA) Beats Q4 Earnings, Issues Cautious 2026 Revenue Outlook

HCA Healthcare (NYSE:HCA) reported strong Q4 2025 earnings, surpassing analyst estimates, although revenue slightly missed expectations. The company also announced a new $10 billion share repurchase authorization and maintained its quarterly dividend. HCA issued cautious revenue guidance for 2026, falling below analyst forecasts, but projected continued EPS growth, indicating a focus on profitability amid a stable operating environment.

https://www.chartmill.com/news/HCA/Chartmill-40468-HCA-Healthcare-NYSEHCA-Beats-Q4-Earnings-Issues-Cautious-2026-Revenue-Outlook

HCA Healthcare stock rises after Q4 results (HCA:NYSE)

HCA Healthcare (HCA) stock rose ~7% in premarket trading despite mixed Q4 results, driven by the announcement of a new $10 billion share buyback program and an increased quarterly dividend to $0.78 per share. The company also provided 2026 financial targets, including adjusted EBITDA of $15.55B-$16.45B and revenue of $76.5B-$80.0B, both largely exceeding analyst consensus.

https://seekingalpha.com/news/4542848-hca-healthcare-stock-rises-after-q4-results

HCA bullish on outpatient expansion amid economic headwinds

HCA Healthcare is reportedly considering expanding its outpatient services, a move that comes after strong fourth-quarter earnings and amidst broader economic challenges. The article highlights HCA's strategic focus on this expansion despite the prevailing economic headwinds. This decision positions HCA to potentially capitalize on growing demand for outpatient care.

https://www.modernhealthcare.com/providers/mh-hca-healthcare-outpatient-q4-earnings/

Markel Group Inc. Purchases 6,250 Shares of HCA Healthcare, Inc. $HCA

Markel Group Inc. increased its stake in HCA Healthcare by 9.1%, purchasing an additional 6,250 shares, bringing their total holdings to 75,213 shares valued at approximately $32.06 million. This comes as HCA Healthcare reported strong quarterly earnings, beating analyst expectations with an EPS of $6.96 and revenue of $19.16 billion, a 9.6% year-over-year increase. The company currently holds a "Moderate Buy" consensus rating from analysts, with various institutional investors also adjusting their positions in the stock.

https://www.marketbeat.com/instant-alerts/filing-markel-group-inc-purchases-6250-shares-of-hca-healthcare-inc-hca-2026-01-27/

Trending Today

Monero ($XMR) Crypto Forecast: Up 6.1% Today

Prime Medicine ($PRME) Stock Forecast: Down 5.1% Today

Intellia Therapeutics, Inc. ($NTLA) Stock Forecast: Down 5.2% Today

Unity Software ($U) Stock Forecast: Up 5.1% Today

Broadridge Financial Solutions Inc.Common Stock ($BR) Stock Forecast: Down 5.0% Today

Marriott International ($MAR) Stock Forecast: Up 8.8% Today

WESCO International, Inc. ($WCC) Stock Forecast: Down 6.8% Today

Masco Corporation ($MAS) Stock Forecast: Up 9.4% Today

Quest Diagnostics Incorporated ($DGX) Stock Forecast: Up 7.3% Today

IQVIA Holdings Inc. ($IQV) Stock Forecast: Down 5.2% Today

HCA Healthcare Inc. Price History

21.03.2025 - HCA Stock was down 5.0%

• Analyst downgrades on HCA Healthcare contributed to the bearish movement in the stock.
• The change in outlook by top Wall Street analysts likely raised concerns among investors, leading to a sell-off.
• Negative sentiment towards the healthcare sector as a whole might have also played a role in the stock's decline.
• Investors may be reevaluating their positions in healthcare stocks amidst changing market dynamics and analyst recommendations.

05.00.2026 - HCA Stock was up 1.7%

• HCA Healthcare's stock rallied steadily due to strong fundamentals, consistent guidance, and a focus on returning cash to shareholders, attracting investor attention away from tech giants.
• The reduction in stake by Gateway Investment Advisers LLC and an EVP could indicate profit-taking after strong Q3 earnings and price target upgrades, contributing to the stock's positive momentum.
• The adoption of advanced robotics for orthopedic surgeries at Marion County HCA Hospitals showcases HCA's commitment to innovation and improving patient outcomes, potentially boosting investor confidence in the company's growth prospects.
• Despite a lower P/E ratio compared to the broader market, investors remain cautious about HCA Healthcare's future earnings volatility or potential threats, reflecting a sense of uncertainty despite the positive market outlook.

25.03.2025 - HCA Stock was down 5.2%

• Following robust financial performance in Q1 where revenue and adjusted EPS surpassed expectations, HCA Healthcare witnessed a decline in its stock price.
• Despite the positive earnings and revenue results, broader market trends and investor sentiment outweighed the strong performance.
• The general optimism in the market, evident in the rise of US futures and consecutive gains on Wall Street, likely influenced profit-taking activities in HCA Healthcare's stock.
• Investor response to market volatility and fluctuating trade setups could have driven the bearish movement in HCA stock, despite its favorable financial outlook.

09.05.2025 - HCA Stock was down 0.2%

• The bearish movement in HCA stock today could be attributed to profit-taking by investors after a prolonged period of growth.
• The long-term investment potential of HCA may have led some investors to reassess their short-term positions, contributing to the bearish movement.
• Market volatility and broader economic factors may have also played a role in the downward movement of HCA stock today.

16.05.2025 - HCA Stock was down 4.1%

• Despite a bullish stance from investors with significant capital, HCA Healthcare experienced a strong bearish movement in the stock market today.
• The discrepancy between the bullish options trading activity and the bearish stock movement could indicate a divergence in market sentiment and actual performance of the company.
• It is possible that external factors, such as broader market conditions or specific company-related news not mentioned in recent updates, contributed to the bearish movement in HCA's stock price today.

27.00.2026 - HCA Stock was up 6.5%

• Strong Q4 earnings were reported by HCA Healthcare, surpassing analyst projections and resulting in a bullish trend in its stock price.
• Investor enthusiasm was fueled by the company's announcement of a new $10 billion share repurchase plan and an uptick in the quarterly dividend.
• Despite a slight miss in revenue expectations for Q4, HCA Healthcare's focus on profitability, sustained EPS growth, and ambitious financial objectives for 2026 provided a favorable perspective for investors.
• Confidence in HCA Healthcare's performance and future prospects was bolstered by Markel Group Inc.'s increased stake and the overall positive sentiment from analysts and institutional investors.

27.00.2026 - HCA Stock was up 7.1%

• Strong Q4 earnings were reported by HCA Healthcare, surpassing analyst expectations and resulting in a bullish movement in the stock.
• Investor confidence was further boosted by the company's announcement of a new $10 billion share repurchase program and an increased quarterly dividend.
• Despite a cautious revenue guidance for 2026, HCA Healthcare's commitment to profitability and continued EPS growth highlighted its ability to effectively navigate a stable operating environment.
• The positive market sentiment towards HCA Healthcare was evident through increased institutional investments, with entities like Markel Group Inc. acquiring additional shares, indicating a growing confidence in the company's performance and future prospects.

28.00.2026 - HCA Stock was down 5.3%

• Despite reporting strong Q4 earnings, HCA Healthcare's stock experienced a bearish movement as the cautious revenue guidance for 2026 fell below analyst expectations.
• The announcement of a new $10 billion share repurchase program and an increased quarterly dividend were not enough to offset concerns about the company's future revenue growth.
• The market may be reacting negatively to economic headwinds, which could impact HCA's revenue projections for the upcoming year.
• The bullish sentiment on outpatient expansion might not have been sufficient to reassure investors about the company's overall growth prospects, leading to the bearish movement in the stock price.

23.03.2025 - HCA Stock was up 5.0%

• HCA's bullish movement today could be attributed to positive analyst estimates for its Q1 earnings, hinting at a strong performance for the company in the healthcare sector.
• Investors may have reacted positively to the deeper insight into key metrics, showing potential growth and profitability for HCA in the upcoming quarter.
• The market movement could also be a result of growing confidence in HCA's ability to navigate the evolving healthcare landscape and deliver value to its shareholders.

22.06.2025 - HCA Stock was down 0.6%

• The bearish movement in HCA stock today could be attributed to the lack of optimistic expectations for its upcoming Q2 earnings:
• Analysts are cautious about the potential for an earnings beat, as the company may not possess the right combination of key ingredients.
• Investors might be adjusting their positions in anticipation of underwhelming performance in key metrics for the quarter ended June 2025.
• The market sentiment seems to be influenced by the uncertainty surrounding HCA Healthcare's earnings growth prospects, leading to a downward pressure on the stock price.

24.09.2025 - HCA Stock was up 2.4%

• HCA Healthcare (HCA) exceeded expectations in Q3 earnings and revenues, reflecting a strong performance during the last quarter.
• Analysts adjusted their forecasts for HCA Healthcare before the earnings announcement, expecting a rise in quarterly earnings per share.
• With a track record of outperforming the market over the past decade, HCA Healthcare has consistently delivered returns to its investors.
• Despite concerns about rising costs affecting Q3 earnings, the company's robust revenue growth has fueled a bullish trend in its stock.

24.10.2025 - HCA Stock was down 1.9%

• The bearish movement in HCA stock today could be due to concerns about increased competition and potential market share loss following Teladoc's aggressive acquisition strategy in the healthcare industry.
• Investors might be worried that Teladoc's expanding global footprint and growth across key segments could pose a threat to HCA's market position and profitability.
• The market might be reacting to the perceived long-term impact of Teladoc's strategic moves on HCA's business prospects, leading to a sell-off of HCA shares in today's trading session.